ALLO
ALLOGENE THERAP (ALLO)
NASDAQ
$1.51-$0.03 (-1.69%)
Price as of Oct 02, 2026 5:36 PM EDT
  • $532.1M
    Market Cap
  • 19.38%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 47
Valuation
ALLO
vs History
vs S&P 500
Profitability
-1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 42
Valuation
ALLO
vs History
vs S&P 500
3-Month Momentum
-4.57%
12-Month Momentum
60.08%
3-Month Risk Adjusted Momentum
-17.11%
12-Month Risk Adjusted Momentum
71.78%

True Yield

N/A
Valuation
ALLO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.0006%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
ALLO
vs History
vs S&P 500
Ohlson's O-Score
5